Moravek Biochemicals, Inc.

Brea, CA

UEI
D5UNRH3YCMD1
CAGE
069G3
Primary NAICS
325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
577 Mercury Ln, Brea, CA 92821, USA
Website
moravek.com
Founded
1975
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $18,910

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Moravek Biochemicals, Inc. is a for-profit corporate entity registered in SAM.gov since 1997, specializing in the custom production of radiolabeled compounds for scientific and pharmaceutical research. Located in Brea, California, the company is structured as a Subchapter S Corporation and operates as a manufacturer of goods with expertise in producing Good Manufacturing Practice (GMP) carbon 14 labeled active pharmaceutical ingredients (APIs). The company has demonstrated a consistent capability to provide specialized radiolabeled materials to federal research and regulatory agencies, positioning itself as a niche scientific manufacturing partner.

Through its federal contract awards, Moravek Biochemicals, Inc. has primarily worked with the Food and Drug Administration (FDA) to produce highly specific radiolabeled compounds. The company's contract awards have included the production of radiolabeled materials such as Pigment Red 22, polyethylene glycols, and polystyrene, with contract values ranging from $18,910 to $114,850. Most of these purchase orders have been designated as Total Small Business set-asides, indicating the company's qualification as a small business concern. The contracts typically involve creating precise radiolabeled compounds with specific activity and radiopurity requirements, demonstrating the company's technical expertise in creating complex scientific materials. The contract completion dates have ranged from 2020 to 2024, showing a consistent track record of delivering specialized scientific manufacturing services to federal agencies.

SBA capabilities narrative

In 1975 Moravek began offering custom carbon-14 (14C)and tritium (3H) labeling services. By 1980 Moravek also offered a catalog of highly purified and documented pure radiolabeled, stable labeled, and non-labeled compounds to support scientific research.

Quick answers

Is Moravek Biochemicals, Inc. registered in SAM.gov?

Yes. Moravek Biochemicals, Inc.'s SAM.gov registration is active through April 24, 2027.

What is Moravek Biochemicals, Inc.'s CAGE code?

Moravek Biochemicals, Inc.'s CAGE code is 069G3, and its Unique Entity ID (UEI) is D5UNRH3YCMD1.

How much has Moravek Biochemicals, Inc. received in federal contracts?

Federal contracts obligated $18,910 to Moravek Biochemicals, Inc. in fiscal years 2023 through 2027.

What is Moravek Biochemicals, Inc.'s most recent federal award?

Moravek Biochemicals, Inc.'s most recent federal contract award is Radioisotope - radiolabeled pigment red 22 (75F40124P00308), from Food and Drug Administration, on July 22, 2024.

On GovTribe

See Moravek Biochemicals, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe